Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 19;11(1):7860.
doi: 10.4081/hr.2019.7860.

Patterns of Prescribing Hydroxyurea for Sickle Cell Disease Patients From a Central Hospital, Saudi Arabia

Affiliations
Free PMC article

Patterns of Prescribing Hydroxyurea for Sickle Cell Disease Patients From a Central Hospital, Saudi Arabia

Assem A Elghazaly et al. Hematol Rep. .
Free PMC article

Abstract

Sickle cell disease (SCD) is a group of inherited disorders of hemoglobin synthesis. It is prevalent in different parts of the world, including the Kingdom of Saudi Arabia. The disease is associated with multiple acute and chronic life-threatening complications. Hydroxyurea (HU) is an effective preventive medication; its use has resulted in decreased morbidity and mortality. However, practice variability, including underutilization of HU, has been reported. No local publication has addressed this issue. The aim of this work is to consider the pattern of HU prescription for SCD patients. This is a retrospective study included patients seen in the outpatient clinics in a central hospital. Cases of medications unavailability or patient refusal to take the drug were not included. A total of 152 patients were included, of them 118 were prescribed HU and 34 were not. In 133 (87.5%) patients, the physician's decision was appropriate. Inappropriate decisions including both under prescription and, to much lesser extent, over utilization had been demonstrated in 19 (12.5%) cases. Impact of raising the healthcare providers' awareness and improving compliance with the updated SCD management recommendations and guidelines deserve further studying. In our local experience, although the majority of HU prescriptions were appropriate, both under prescription and to a lesser extent, overutilization was demonstrated.

Keywords: HU; Over- and under prescription; SCD.

Conflict of interest statement

Conflict of interest: the authors declare no potential conflict of interest.

Similar articles

See all similar articles

References

    1. National Institute for Health and Clinical Excellence (NICE). Management of an acute painful sickle cell episode in hospital. 2012. Available from: https://www.nice.org.uk/guidance/cg143
    1. World Health Organization Genomic Resource Centre. Genes and human disease, monogenic diseases: Sickle cell disease. Victor Boulyjenkov. Available from: http://www.who.int/genemics/geneticdiseases (accessed on May 22, 2018).
    1. El Hazmi MA, Warsy AS, al-Swailem AR, et al. Sickle cell gene in the population of Saudi Arabia. Hemoglobin 1996;20:187-98. - PubMed
    1. Abdulaali MK. Sickle cell disease patients in eastern province of Saudi Arabia suffer less severe acute chest syndrome than patients with African haplotypes. Ann Thorac Med 2007;2: 158-62. - PMC - PubMed
    1. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22. - PubMed

Grant support

Funding: none.
Feedback